Increasing prevalence of coronary artery diseases to drive the UAE interventional cardiology devices market in the forecast period, 2023-2027
According to TechSci Research report, “UAE Interventional Cardiology Devices Market – By Region, Forecast and Opportunities, 2017-2027”, the UAE interventional cardiology devices market is anticipated to grow at a significant rate in the forecast period, 2023-2027. Interventional cardiology is the branch of cardiology that concerns with catheter-based treatment of cardiovascular diseases, such as congenital heart defect (CHD), aneurysm, and coronary artery disease. The procedure requires the insertion of catheter into femoral artery or vein or any large peripheral artery and through catheter whole procedure is performed by using fluoroscopy. The rise in prevalence of coronary artery diseases, technological advancements, and unhealthy lifestyle are the primary factors driving the demand for the UAE interventional cardiology devices market. In UAE, as the population of overweight and obese are increasing, the overall prevalence of heart related ailments is rising too. This is due to the lack of physical activity and unhealthy choices made by the people in the country. Growing expansion of healthcare facilities, increasing investments on healthcare sector, rising patient awareness and geriatric population are expected to influence the market demand.
However, a stringent regulatory requirement, high manufacturing cost of devices and the availability of effective first-line treatments which may hamper the growth of the market in the forecast period.
Browse over XX market data Figures spread through 110 Pages and an in-depth TOC on "UAE Interventional Cardiology Devices Market"
The UAE Interventional Cardiology Devices market is segmented into product, end user, and company.
Based on product, the market is divided into angioplasty balloons, angioplasty stents, structural heart devices, catheters, plaque modification devices, hemodynamic flow alteration devices, and other. The catheters segment is expected to witness a rise over the forecast period due to the expanding prevalence of coronary artery diseases (CAD), and the growing awareness about the benefits of the early diagnosis. Moreover, technological advancements and product innovations taking place in the Catheters sub-segment are likely to propel UAE interventional cardiology devices market growth.
Based on end user, the market is divided into hospitals & clinics, ambulatory surgical centers, and others. The hospital segment is anticipated to grow at the highest rate during the forecast period which attributes to the increasing number of hospitals and the rising demand for minimally invasive treatment options & procedures for heart-related diseases. For instance, in 2019, health expenditure per capita for United Arab Emirates was 1,843 US dollars.
Major operating companies operating in UAE interventional cardiology devices market are:
- Riomed Medical Supplies LLC
- B Braun Medical Gulf FZ-LLC
- GE Healthcare UAE
- Omron Healthcare UAE
- Masimo Corporation UAE
- Philips Healthcare UAE
- Nihon Kohden Middle East FZE
Customers can also request for 10% free customization on this report.
“UAE is expected to witness a significant growth in the upcoming years due to increasing prevalence of coronary artery diseases, technological advancements, and unhealthy lifestyle. Also, owing to the non-invasive surgeries, the demand for Interventional Cardiology Devices rises. Changing lifestyle such as lack of activity, unhealthy choices, and sedentary lifestyle are the primary reason due to which the UAE interventional cardiology devices market is expected to grow through 2027” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based global management consulting firm.
“UAE Interventional Cardiology Devices Market - By Region, Competition Forecast & Opportunities, 2027 Segmented By Product Type (Angioplasty Balloons, Angioplasty Stents, Structural Heart Devices, Catheters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Others), By End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others), By Region”, has evaluated the future growth potential of UAE interventional cardiology devices and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in UAE interventional cardiology devices market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com
The global interventional cardiology devices market size was valued at USD 15.14 billion in 2013 and is anticipated to reach USD 25.16 billion by 2020.
Global interventional cardiology devices market is expected to experience brisk growth due to rise in heart related problems across the world over the forecast period.
Interventional cardiology is numerous non-surgical processes for treating cardiovascular related problems.
Several devices used in these procedures include stent, PTCA balloon and catheters among several others.
The diseases that are treated using interventional cardiology comprise coronary artery diseases, peripheral vascular disease and heart valve disease mainly.
Research and development across the world for technological advancement in order to achieve competitive advantage is estimated to further fuel the market demand over the forecast period.
Factors driving the growth of this market include the increasing incidence of cardiovascular diseases and the launch of innovative and technologically advanced interventional cardiology devices.
The interventional cardiology devices market is consolidated in nature due to the presence of a large number of players.
The key players in the market are Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B.Braun (Germany), C.R.
It also distributes its products through direct sales representatives in the US and a combination of direct and indirect sales representatives worldwide.
Boston Scientific is a well-known player that develops, manufactures, and markets medical devices that are used in a broad range of interventional medical specialties.
In 2015, Boston Scientific partnered with C. R. Bard to distribute its Lutonix 035 Drug-coated Balloon in the US.
19 February 2020 - The global Interventional Cardiology Devices Market size was valued at USD 15.14 billion in 2013 and is anticipated to reach USD 25.16 billion by 2020.
Global interventional cardiology devices market is expected to experience brisk growth due to rise in heart related problems across the world over the forecast period.
Increase in disposable income is presumed to complement the intervention cardiology market growth over the next eight year period.Interventional cardiology is numerous non-surgical processes for treating cardiovascular related problems.
Several devices used in these procedures include stent, PTCA balloon and catheters among several others.
The diseases that are treated using interventional cardiology comprise coronary artery diseases, peripheral vascular disease and heart valve disease mainly.Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/interventional-cardiology-devices-marketGrowth in geriatric population is expected to boost the market growth in the near future.
Moreover increasing coronary artery disease is presumed to further propel the industry growth over the next eight year period Rise in demand for minimal procedures related with invasive angioplasty.
